维普中文期刊产品整合服务
25篇 您的检索式:作者名="Giotta"
    题名 作者 年代 出处 被引量
1Carboplatin in combi- nation with raltitrexed in recurrent and metastatic head and neck squamous cellcarcinoma 显示文摘Galetta D Giotta F Rosati G 2005Anticancer Res2005,25,7:1
2Tumor invasion and the extracellular matrix显示文摘Giotta LA Rao CN Barsky SH 1983Lab Invest1983,49,:1
3Heavy metal ion influence on the photosynthetic growth of Rhodobactersphaeroides 显示文摘Giotta L Agostiano A haliano F 2006Chemosphere2006,62,9:1
4Efficacy and safety of zoledronic acid in patients with breast cancer metastatic to bone: a muhicenter clinical trial显示文摘Carteni G Bordonaro R Giotta F 2006Oncologist2006,11,7:1
5A Multieenter Phase Ⅱ random- ized trial ofdocetaxel/gemcitabine versus docetaxel/capecitabine as first - line treatment for advanced breast cancer : A Gruppe Oncolog- ico Italia Meridionale Study 显示文摘Vici P Giotta F Di Laura L 2011Oncology2011,81,34:1
6Efficacy and Safety of Zole-dronic Acid in Patients with Breast Cancer Metastatic to Bone:A Mul-ticenter Clinical显示文摘Carteni G Bordonaro R Giotta F 2006The oncologist2006,11,:1
7Efficacy and safety of zoledronic acid inpatients with breast cancer metastatic to bone:a multicenter clinical trial显示文摘Carteni G Bordonaro R Giotta F 0,,:1
8Quality of life,fatigue and depression in Italian long-term breast cancer survivors显示文摘Romito F Cormio C Giotta F 2012Support Care Cancer2012,20,11:1
9A multicenter phase II randomized trial of docetaxel/gemcitabine versus docetaxel/ capecitabine as first-line treatment for advanced breast canc- er~a gruppo oncologieo Italia meridionale study显示文摘Vici P Giotta F Di Lauro L 2011Oncolo- gy2011,81,34:1
10A muhicenter phase II randomized trial of docetaxel/gemcitabine versus docetaxel/capecitabine as first-linetreatment for advanced breast cancer: A gruppo oncologico italia merid- ionale study显示文摘Vici P Giotta F Di Lauro L 2011Oncology2011,81,34:1
11Gemcitabine and docetaxel every 2 weeks in advanced non-small cell lung cancer:a phase Ⅱ study of the gruppo oncologico italia meridionale显示文摘Galetta D Gebbia V Giotta F 2002Lung Cancer2002,38,1:1
12A muhicenter phase II ran- domized trial of docetaxel/gemcitabine versus docetaxel/capecit- abine as first-line treatment for advanced breast cancer: a Gruppo Oncologico Italia Meridionale study显示文摘Vici P Giotta F Di Lauro L 2011Oncology2011,81,34:1
13Efficacy and safety of zoledronic acid in patients with breast cancer metastatic to bone: a multicenter clinical trial显示文摘Cartcni G Bordonaro R Giotta F 2007Oncologist2007,,11:1
14A multicenter phase II randomized trial of doeetaxel/gemcitabine versus docetaxel/ capecitabine as first-line treatment for advanced breast cancer: A gruppo oncologico italia meridionale study 显示文摘VICI P GIOTTA F DI LAURO L 2011Ontology2011,81,34:1
15A Multicenter Phase Ⅱ ran- domized trial of docetaxel/gemcitabine versus docetaxel/ eapecitabine as first- line treatment for advanced breast cancer: A Gruppo Oncologico Italia Meridionale Study显示文摘Vici P Giotta F Di Lauro L 2011Oncology2011,81,34:1
16Endocrine and metabolic effects of insulin sensitizers in the treatment of patients with polycystic ovary syndrome and hyperinsulinaemia 显示文摘GIOTTA L DELEO V FARRINA M 2001Gynecol Obstet Invest2001,51,1:1
17Endiocrine and metabolic effects of octreotide, a so matostatin analogue, in lean PCOS patients with either hyperinsulinaemia or lean nor moininsulinaemia显示文摘GIOTTA L DELEO V GALVANI F 1999Hum Reprod1999,14,12:1
18Efficacy and safety of zoledronic acid in patients with breast cancer metastatic to bone:a multicenter clinical trial显示文摘Carteni G Bordonaro R Giotta F 2006Oncologist2006,11,7:1
19Efficacy and safety of zoledronic acid in patients with breast cancer metastatic to bone: a multicenter clinical trial显示文摘Cartenl G Bordonaro R Giotta F 2006Oncologist2006,11,7:1
20Efficacy and safety of zoledronic acid in patients with breast cancer metastatic to bone:a multicenter clinical trial显示文摘Carteni G Bordonaro R Giotta F 2006Oncologist2006,11,7:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费